Vizgen, Inc. filed a Form D with the Securities and Exchange Commission on 2026-01-12.
Vizgen, Inc. filed a Form D notice of an exempt securities offering with the SEC on January 12, 2026. The filing reports $47.79M sold. Its industry group is Biotechnology. It names Robert Carson (Executive Officer, Director), Simona Levi (Executive Officer), Matthew Posard (Director) (SEC Form D, January 12, 2026).
Is this your company?
Sell to companies like Vizgen, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-01-12 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Vizgen, Inc.
Free to see. No signup.
More on the people and the money behind Vizgen, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed within 90 days of this one, largest first.
Get an email when Vizgen, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Vizgen, Inc. raises, hires or launches. No email unless you switch it on.
Watch Vizgen, Inc. →Get the full cited report on Vizgen, Inc.
What the filing shows about Vizgen, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Vizgen, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Vizgen, Inc.'s address as 150 Bear Hill Road, Waltham, MA 02451.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Vizgen, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Vizgen, Inc. is a registered filer with the SEC (CIK 1790415) and has filed since 2024-10-22. 3 filings are on record, the latest on 2026-01-12.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Vizgen, Inc.'s Form D of 2026-01-12 names Robert Carson, Simona Levi, Matthew Posard and 4 more as its officers, directors or promoters.
Its new offerings report $158.87M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $47.79M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Robert Carson is named as Executive Officer and Director on the Form D that Vizgen, Inc. filed with the SEC on 12 January 2026, one of 7 people that filing names.
Simona Levi is named as Executive Officer on the Form D that Vizgen, Inc. filed with the SEC on 12 January 2026, one of 7 people that filing names.
Matthew Posard is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 12 January 2026, one of 7 people that filing names.
Keith Crandell is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 12 January 2026, one of 7 people that filing names.
Andrea Jackson is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 12 January 2026, one of 7 people that filing names.
David Walt is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 12 January 2026, one of 7 people that filing names.
Christian Uhrich is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 12 January 2026, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2026-01-12 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Vizgen, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Vizgen, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vizgen, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Vizgen, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Vizgen, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Vizgen, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/vizgen-inc-form-d-26000001